- Home
- RPRX vs GEN Comparison
RPRX vs GEN Comparison
Compare RPRX & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- GEN
- Stock Information
- Founded
- RPRX 1996
- GEN 1982
- Country
- RPRX United States
- GEN United States
- Employees
- RPRX N/A
- GEN N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- GEN Computer Software: Prepackaged Software
- Sector
- RPRX Health Care
- GEN Technology
- Exchange
- RPRX Nasdaq
- GEN Nasdaq
- Market Cap
- RPRX 16.2B
- GEN 16.9B
- IPO Year
- RPRX 2020
- GEN N/A
- Fundamental
- Price
- RPRX $38.51
- GEN $25.78
- Analyst Decision
- RPRX Strong Buy
- GEN Buy
- Analyst Count
- RPRX 3
- GEN 7
- Target Price
- RPRX $46.00
- GEN $35.43
- AVG Volume (30 Days)
- RPRX 3.2M
- GEN 3.7M
- Earning Date
- RPRX 11-05-2025
- GEN 11-06-2025
- Dividend Yield
- RPRX 2.28%
- GEN 1.94%
- EPS Growth
- RPRX N/A
- GEN N/A
- EPS
- RPRX 1.75
- GEN 0.91
- Revenue
- RPRX $2,349,844,000.00
- GEN $4,473,000,000.00
- Revenue This Year
- RPRX $36.16
- GEN $24.70
- Revenue Next Year
- RPRX $2.04
- GEN $4.97
- P/E Ratio
- RPRX $22.00
- GEN $28.27
- Revenue Growth
- RPRX 3.70
- GEN 16.15
- 52 Week Low
- RPRX $24.05
- GEN $22.74
- 52 Week High
- RPRX $41.24
- GEN $32.22
- Technical
- Relative Strength Index (RSI)
- RPRX 56.61
- GEN 32.46
- Support Level
- RPRX $36.03
- GEN $25.79
- Resistance Level
- RPRX $41.24
- GEN $26.46
- Average True Range (ATR)
- RPRX 1.17
- GEN 0.58
- MACD
- RPRX 0.28
- GEN -0.03
- Stochastic Oscillator
- RPRX 48.17
- GEN 40.31
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.